Cyclooxygenase 2 (COX-2)
Cyclooxygenase-2 (COX-2), also called prostaglandin-endoperoxide synthase 2 or prostaglandin G/H synthase 2, is a membrane-anchored, heme-containing enzyme encoded by the PTGS2 gene.
Cyclooxygenase-2 (COX-2), also called prostaglandin-endoperoxide synthase 2 or prostaglandin G/H synthase 2, is a membrane-anchored, heme-containing enzyme encoded by the PTGS2 gene. It is bifunctional, catalyzing two sequential reactions in prostanoid biosynthesis: a cyclooxygenase reaction that converts arachidonic acid to prostaglandin G2 (PGG2), and a peroxidase reaction that reduces PGG2 to prostaglandin H2 (PGH2). PGH2 serves as the common precursor from which downstream synthases generate bioactive prostanoids, including prostaglandin E2 (PGE2), thromboxanes, and prostacyclin. Unlike the constitutively expressed isoform COX-1, COX-2 protein is largely absent from most tissues at baseline and is rapidly induced by inflammatory and mitogenic stimuli. Its expression is driven by proinflammatory cytokines such as Interleukin-6 (IL-6) and interleukin-1β, by toll-like receptor 4 (TLR4) engagement, by reactive oxygen species, and by transcriptional programs converging on nuclear factor kappa B (NF-κB) and MAPK signaling.
COX-2 is among the most heavily pursued drug targets in medicine. Non-steroidal anti-inflammatory drugs, including aspirin and diclofenac, produce their analgesic and anti-inflammatory effects largely by inhibiting COX enzymes, while selective COX-2 inhibitors such as celecoxib were developed to retain anti-inflammatory efficacy with less gastrointestinal toxicity than non-selective inhibition. Because COX-2 activity links arachidonic acid metabolism to tissue inflammation, it is a recurring node in osteoarthritis, where its inhibition is studied alongside cartilage repair and macrophage polarization; in ischemic stroke and neurodegeneration, where COX-2-driven neuroinflammation and microglial activation are implicated in Alzheimer's disease and diet-associated depressive phenotypes; and in oncology, where PGE2 output supports tumor growth, angiogenesis, immune evasion, and altered lipid metabolism in cancers such as high-grade serous ovarian carcinoma and lung adenocarcinoma. COX-2 also appears repeatedly as a core predicted target in network-pharmacology and molecular-docking studies of natural products and plant flavonoids such as quercetin, typically alongside IL-6 and Tnf, and purified COX-2 protein is widely used in enzyme-inhibition assays and immobilized-enzyme screening platforms for inhibitor discovery.
Where the papers sit
25 papers from the last 6 months study Cyclooxygenase 2 (COX-2) directly · updated from PubMed 12 Nov 2026
Study type 0 clinical trials · 5 human data · 17 preclinical · 3 unclassified
Themes one subject
Those 25 are all about one subject.
-
COX-2 Inflammation and Drug Discovery
COX-2 is being studied as an inflammatory target across cancer, neuroinflammation, arthritis, metabolic disease and neurological disorders. Natural products and synthetic derivatives are being developed as selective inhibitors, supported by computational design and screening workflows. Recurring mechanisms include PGE2 signaling, TLR4/NF-kB activation, ferroptosis resistance, lipid metabolism and immune resistance. Evidence remains predominantly preclinical and context-specific, with no single therapeutic direction yet dominant.
Papers
The 25 papers from the last 6 months that study Cyclooxygenase 2 (COX-2) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
COX-2 Inflammation and Drug Discovery (25)
- Integrative computational analysis of public fecal lipidomics and transcriptomics datasets suggests a candidate association between the COX-2 pathway and CE(20:4) in colorectal adenoma-carcinoma progression. PloS one · 25 Sept 2026 PMID 42789583
- Design, synthesis, structure-activity relationship and in-silico studies of novel pyrazolo[1,5-a]pyrimidine derivatives as selective COX-2 inhibitors with promising anti-inflammatory activity and safety profile. Bioorganic chemistry · 22 Sept 2026 PMID 42772098
- Design, synthesis and multitarget evaluation of cyclopropyl-appended thiohydantoin derivatives as dual cholinesterase and COX inhibitors with antioxidant activity: a combined experimental and computational study. Journal of computer-aided molecular design · 11 Sept 2026 PMID 42726329
- Neuroprotective Effect of Isorhapontigenin (ISO) Against LPS-Induced Neurodegenerative Condition via TLR4/RAGE-Mediated p-NF-kB Activation. Molecular neurobiology · 5 Sept 2026 PMID 42700283
- Bioreactor-based production of eumelanin nanoparticles by Streptomyces glaucescens NEAE-H: physicochemical characterization, anticancer and anti-inflammatory activities, and in silico analysis. Scientific reports · 2 Sept 2026 PMID 42680801
- Exploring the Active Components of Buqi-Zhitong-Decoction and Its Therapeutic Potential for Chronic Fatigue Syndrome Based on LC-MS/MS and Network Pharmacology. Journal of separation science · 29 Aug 2026 PMID 42667244
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Artificial intelligence-guided discovery of marine scalaranes as selective COX-2 inhibitors through machine learning and molecular modelling. Organic & biomolecular chemistry · 18 Aug 2026 PMID 42610772
- PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma. Journal for immunotherapy of cancer · 12 Aug 2026 PMID 42586608
- Celastrol attenuates synovial inflammation and experimental arthritis by modulating PTGS2-associated ferroptosis resistance in fibroblast-like synoviocytes. Journal of molecular histology · 29 Jul 2026 PMID 42525168
- Immunomodulatory activity of Inula viscosa (L.) compounds identified via LC-ESI-MS and their COX-2-targeted anti-inflammatory potential: in vitro, in vivo and in silico analysis. Journal of computer-aided molecular design · 25 Jul 2026 PMID 42501144
- Multi-Omics Profiling of High-Grade Serous Ovarian Cancer Reveals an Inflammation-Related Lipid Metabolism Subtype Associated With Platinum Resistance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 17 Jul 2026 PMID 42466711
- Aspirin alleviates long-term high-fat diet-induced depressive-like behavior in male mice via suppressing arachidonic acid-mediated microglial activation and neuroinflammation. Molecular psychiatry · 15 Jul 2026 PMID 42457861
- A Principle-Guided Multistep Workflow for Screening Potential Quality Marker Candidates of Sanqi Shangyao Tablet Based on UHPLC-Q-Orbitrap MS, In Silico Screening, and In Vitro Validation. Biomedical chromatography : BMC · 15 Jul 2026 PMID 42453089
- Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer's disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking. PloS one · 6 Jul 2026 PMID 42406869
- Fluorescent labeled enzyme immobilized on chitosan-coated magnetic microspheres for potential cyclooxygenase-2 inhibitors screening accompanied with molecular modeling and in situ cell imaging. Mikrochimica acta · 2 Jul 2026 PMID 42393368
- Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
- A COX-2 PROTAC Nanodrug for osteoarthritis therapy via enhancing cartilage repair and reprogramming macrophage polarization. Journal of controlled release : official journal of the Controlled Release Society · 28 Jun 2026 PMID 42365877
- Design, synthesis, biological evaluation and histopathological studies of Pyridazine and Pyrazoline derivatives as potential anti-inflammatory agents. Bioorganic chemistry · 25 Jun 2026 PMID 42348939
- Assessing the Therapeutic Efficacy of Xihuang Pill in Lung Adenocarcinoma by Single-Cell Raman Spectroscopy. Analytical chemistry · 23 Jun 2026 PMID 42336477
- Neuroprotective efficacy of Curcumae Rhizoma against ischemic stroke via attenuation of COX-2-mediated neuroinflammation: a systematic study predicting thrombin inhibition and highlighting alexandrin and hederagenin. Metabolic brain disease · 16 Jun 2026 PMID 42301551
- Discovery of novel imidazo[2,1-b]thiazole-hydrazone hybrids as multi-target anticancer agents: Dual PARP-1/COX-2 inhibition and MetAP-2 modulation. Bioorganic chemistry · 4 Jun 2026 PMID 42242020
- Integrating machine learning and WGCNA to identify core candidate genes and decipher immune-related molecular networks in TcdA/TcdB-associated CDI. Antonie van Leeuwenhoek · 2 Jun 2026 PMID 42230843
- One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction. European journal of medicinal chemistry · 26 May 2026 PMID 42190432
- Qingfei Tongluo Formula attenuates COPD-associated ferroptosis by restoring arachidonic acid metabolic balance via dual inhibition of prostaglandin-endoperoxide synthase 2 and soluble epoxide hydrolase 2. Phytomedicine : international journal of phytotherapy and phytopharmacology · 25 May 2026 PMID 42184495
By study type
Human data, design not indexed (5)
- Integrative computational analysis of public fecal lipidomics and transcriptomics datasets suggests a candidate association between the COX-2 pathway and CE(20:4) in colorectal adenoma-carcinoma progression. PloS one · 25 Sept 2026 PMID 42789583
- Design, synthesis and multitarget evaluation of cyclopropyl-appended thiohydantoin derivatives as dual cholinesterase and COX inhibitors with antioxidant activity: a combined experimental and computational study. Journal of computer-aided molecular design · 11 Sept 2026 PMID 42726329
- Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer's disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking. PloS one · 6 Jul 2026 PMID 42406869
- Fluorescent labeled enzyme immobilized on chitosan-coated magnetic microspheres for potential cyclooxygenase-2 inhibitors screening accompanied with molecular modeling and in situ cell imaging. Mikrochimica acta · 2 Jul 2026 PMID 42393368
- Integrating machine learning and WGCNA to identify core candidate genes and decipher immune-related molecular networks in TcdA/TcdB-associated CDI. Antonie van Leeuwenhoek · 2 Jun 2026 PMID 42230843
Preclinical: animal, cell and lab studies (17)
- Design, synthesis, structure-activity relationship and in-silico studies of novel pyrazolo[1,5-a]pyrimidine derivatives as selective COX-2 inhibitors with promising anti-inflammatory activity and safety profile. Bioorganic chemistry · 22 Sept 2026 PMID 42772098
- Neuroprotective Effect of Isorhapontigenin (ISO) Against LPS-Induced Neurodegenerative Condition via TLR4/RAGE-Mediated p-NF-kB Activation. Molecular neurobiology · 5 Sept 2026 PMID 42700283
- Bioreactor-based production of eumelanin nanoparticles by Streptomyces glaucescens NEAE-H: physicochemical characterization, anticancer and anti-inflammatory activities, and in silico analysis. Scientific reports · 2 Sept 2026 PMID 42680801
- Exploring the Active Components of Buqi-Zhitong-Decoction and Its Therapeutic Potential for Chronic Fatigue Syndrome Based on LC-MS/MS and Network Pharmacology. Journal of separation science · 29 Aug 2026 PMID 42667244
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Artificial intelligence-guided discovery of marine scalaranes as selective COX-2 inhibitors through machine learning and molecular modelling. Organic & biomolecular chemistry · 18 Aug 2026 PMID 42610772
- PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma. Journal for immunotherapy of cancer · 12 Aug 2026 PMID 42586608
- Celastrol attenuates synovial inflammation and experimental arthritis by modulating PTGS2-associated ferroptosis resistance in fibroblast-like synoviocytes. Journal of molecular histology · 29 Jul 2026 PMID 42525168
- Immunomodulatory activity of Inula viscosa (L.) compounds identified via LC-ESI-MS and their COX-2-targeted anti-inflammatory potential: in vitro, in vivo and in silico analysis. Journal of computer-aided molecular design · 25 Jul 2026 PMID 42501144
- A Principle-Guided Multistep Workflow for Screening Potential Quality Marker Candidates of Sanqi Shangyao Tablet Based on UHPLC-Q-Orbitrap MS, In Silico Screening, and In Vitro Validation. Biomedical chromatography : BMC · 15 Jul 2026 PMID 42453089
- Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
- Design, synthesis, biological evaluation and histopathological studies of Pyridazine and Pyrazoline derivatives as potential anti-inflammatory agents. Bioorganic chemistry · 25 Jun 2026 PMID 42348939
- Assessing the Therapeutic Efficacy of Xihuang Pill in Lung Adenocarcinoma by Single-Cell Raman Spectroscopy. Analytical chemistry · 23 Jun 2026 PMID 42336477
- Neuroprotective efficacy of Curcumae Rhizoma against ischemic stroke via attenuation of COX-2-mediated neuroinflammation: a systematic study predicting thrombin inhibition and highlighting alexandrin and hederagenin. Metabolic brain disease · 16 Jun 2026 PMID 42301551
- Discovery of novel imidazo[2,1-b]thiazole-hydrazone hybrids as multi-target anticancer agents: Dual PARP-1/COX-2 inhibition and MetAP-2 modulation. Bioorganic chemistry · 4 Jun 2026 PMID 42242020
- One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunction. European journal of medicinal chemistry · 26 May 2026 PMID 42190432
- Qingfei Tongluo Formula attenuates COPD-associated ferroptosis by restoring arachidonic acid metabolic balance via dual inhibition of prostaglandin-endoperoxide synthase 2 and soluble epoxide hydrolase 2. Phytomedicine : international journal of phytotherapy and phytopharmacology · 25 May 2026 PMID 42184495
Unclassified: not yet indexed with MeSH (3)
- Multi-Omics Profiling of High-Grade Serous Ovarian Cancer Reveals an Inflammation-Related Lipid Metabolism Subtype Associated With Platinum Resistance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 17 Jul 2026 PMID 42466711
- Aspirin alleviates long-term high-fat diet-induced depressive-like behavior in male mice via suppressing arachidonic acid-mediated microglial activation and neuroinflammation. Molecular psychiatry · 15 Jul 2026 PMID 42457861
- A COX-2 PROTAC Nanodrug for osteoarthritis therapy via enhancing cartilage repair and reprogramming macrophage polarization. Journal of controlled release : official journal of the Controlled Release Society · 28 Jun 2026 PMID 42365877
Written from 25 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-09-13 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.